, ,

Pinealon 10 mg

45,90 €

A short research peptide studied in neuronal resilience and oxidative-stress models.

Pinealon, also known as the EDR peptide, is investigated in laboratory and animal research involving neuronal viability, cellular signalling and learning-related endpoints.

Research areas: Neuronal biology · Oxidative stress · Brain ageing

Availability: Na sklade

RECOMMENDED LABORATORY ACCESSORY
Bacteriostatic Water 3 / 10 ml
Bacteriostatic Water (BAC)Optional laboratory diluent. Confirm compatibility with the material documentation.View product details →
Synthetic tripeptide · Glu–Asp–Arg (EDR)

Pinealon 10 mg

A synthetic tripeptide investigated in neuronal stress responses, cell-survival signalling and experimental models of brain ageing.

Technical product dataIdentity and specification at a glance
Declared content10 mg
Physical formLyophilized research material
Packaging1 laboratory vial
Peptide typeSynthetic tripeptide
SequenceGlu–Asp–Arg (EDR)
Molecular formulaC15H26N6O8 — reference peptide, excluding counterions and water
Molecular weight418.41 g/mol — reference peptide
Reference identityPubChem CID 10273502
Chemical formThe reference formula describes the peptide itself. Salt form, counterions and hydration state must be confirmed from the documentation for the supplied batch.
Purity and measured contentRefer to the analytical report for the specific batch; no batch result is asserted on this page.
Storage — unopened powderKeep the sealed freeze-dried vial at −20 °C, dry and protected from light. Let the closed vial reach room temperature before opening to limit condensation.
Storage — after reconstitutionAfter preparation with bacteriostatic water, keep refrigerated at 2–8 °C and protected from light. Do not freeze; minimize repeated warming and cooling.
Handling and traceabilityRecord the lot number, receipt date, opening date and preparation conditions. Consult the matching safety and analytical documentation before laboratory handling.
Solubility / reconstitutionBacteriostatic water — 1 ml per vial
Research areas

Where Pinealon is being investigated

01

Neuronal viability

Survival of nerve-cell populations exposed to experimental oxidative stress.

02

Oxidative stress

Accumulation of reactive oxygen species and associated cellular injury markers.

03

Cell signalling

ERK-related responses, gene-expression hypotheses and cellular adaptation.

04

Learning-related models

Behavioural and neuronal endpoints in selected rodent experiments.

Scientific background

What is Pinealon?

Pinealon is a synthetic peptide composed of glutamic acid, aspartic acid and arginine. Its sequence is abbreviated EDR. Researchers use it to examine how a defined short peptide may influence the response of cells to stress, particularly in experimental nervous-system models.

The name can be confused with other pineal-associated peptides. Pinealon is the three-amino-acid EDR sequence; Epithalon is the different four-amino-acid AEDG sequence. Their experimental findings and proposed mechanisms should be assessed separately.

Mechanisms under investigation

Biological pathways in the research

ROS

The cellular stress response

A 2011 study tested Pinealon in several cell systems, including cerebellar neurons and PC12 cells. Researchers reported reduced accumulation of reactive oxygen species and less necrotic cell death under the tested conditions. The relevance depends on the model and experimental conditions.

ERK 1/2

Signalling and cell-cycle responses

The same study examined changes in the timing of ERK 1/2 activation and cell-cycle behaviour. These results suggest that the experimental response is more complex than a simple antioxidant effect. They do not establish a complete mechanism in humans.

Neuronal structure

Synaptic and regulatory hypotheses

Research on EDR also examines neuronal structure and possible regulation of gene expression. A 2021 experimental publication investigated EDR and KED in models related to Alzheimer’s disease. These model-based investigations should not be interpreted as evidence that Pinealon treats dementia.

Evidence review

What does the research show?

Cell experiments · 2011

Viability under oxidative stress

The initial cell work provides a basis for studying oxidative-stress and survival endpoints together. It supports follow-up experiments rather than a claim of proven protection in people.

Rat model · 2012

Prenatal hyperhomocysteinaemia

A study of rat offspring exposed to a specific prenatal metabolic-stress model reported changes in spatial learning and neuronal resistance to oxidative stress after maternal Pinealon treatment. This specialised animal model is not equivalent to supplementation in healthy adults.

Experimental research · 2021

Neuronal connections

A study of short tripeptides explored neuronal and dendritic-spine endpoints in Alzheimer-related mouse models. This extends the range of experimental questions without establishing clinical efficacy.

Evidence in context

From a model to a clinical claim

The strongest references presented here concern cell and animal research. They do not establish reliable cognitive enhancement in healthy people, a treatment for neurological disease or an effective human dosing regimen. Independent replication and well-designed clinical studies remain important.

Research & publications

Selected reading

Research explained

Understanding the Pinealon research

Cellular stress

What oxidative-stress measurements mean

Reactive oxygen species are molecules involved in cellular signalling that can also contribute to damage when their production exceeds cellular control. Pinealon research examines their accumulation together with cell viability. Measuring both helps distinguish a change in a stress marker from a change in the number of surviving cells under the particular experimental conditions.

Neuronal structure

Why dendritic spines are studied

Dendritic spines are small projections involved in many connections between nerve cells. Changes in their number and structure are useful experimental endpoints in neuroscience. Studies of EDR examine these structural observations alongside cellular and behavioural findings. A result in a cultured neuron or a disease model answers a narrower question than a demonstrated improvement in human memory.

Practical information

Product details at a glance

01 · Package

What the package contains

One laboratory vial labelled Pinealon 10 mg, supplied as lyophilized research material. The labelled peptide amount describes nominal content; it does not specify the total mass of peptide, counterions, residual water or any formulation ingredients.

02 · Chemical identity

Reading the molecular specification

The molecular formula and molecular weight above refer to the reference peptide. They are distinct from measured vial content and do not confirm the salt form of the supplied batch. The sequence can be checked against PubChem CID 10273502.

03 · Analytical results

Purity and content answer different questions

Chromatographic purity describes the relative chromatographic signal assigned to the peptide under a particular test method. Peptide content measures an amount. A purity percentage alone does not confirm the labelled milligram content, sterility or endotoxin status; each requires its own appropriate assessment.

04 · Storage and preparation

Use the documentation for the supplied material

Store the sealed freeze-dried vial at −20 °C, dry and protected from light. Before opening, allow the closed vial to reach room temperature to limit condensation. After preparation with bacteriostatic water, store at 2–8 °C, protected from light. Do not freeze the prepared solution and minimize repeated warming and cooling. Record the preparation date and follow the batch documentation for the applicable use-by period.

Product documentation

Batch-specific analytical information

Published research describes the peptide sequence; it does not verify the identity or quality of an individual vial. Match the lot identifier to its own analytical report. Purity, measured content and endotoxin findings should only be quoted where the corresponding tests have been performed and documented.

Browse the laboratory results library →

Research-use notice

For laboratory and analytical research only. Not for human or veterinary use.

Weight 0,01 kg

Reviews

There are no reviews yet.

Be the first to review “Pinealon 10 mg”

Your email address will not be published. Required fields are marked *

Welcome to Veyrona Labs

Scroll to Top